Innovative synthesis of biologically active peptides using tandem proteolysis and precision bacterial fermentation. This method creates peptides with therapeutic, immunomodulatory, and metabolic properties, plus unique taste profiles for nutrition and gastronomy.
This innovative approach utilizes tandem methodologies of proteolysis and precision bacterial fermentation to synthesize biologically active peptides. The resulting peptides exhibit a broad spectrum of biological activities, including therapeutic, immunomodulatory, and metabolic regulation capabilities. Additionally, these peptides offer unique taste profiles, presenting novel opportunities in nutrition and gastronomy. By combining these two methodologies, the process achieves a level of control and specificity in peptide synthesis that is unattainable by either method alone.
The technology currently stands at TRL 5, indicating that the concept has been validated in a laboratory setting and is ready for further development and validation in relevant environments.
The University of Nebraska–Lincoln is a comprehensive public research university and the flagship campus of the University of Nebraska system, combining land-grant reach with a collaborative, industry-engaged culture. A research and technology park adjacent to campus provides modern wet and dry labs, greenhouses, offices, and conferencing, enabling companies to co-locate with faculty and access shared equipment and pilot environments. A statewide extension network links university expertise with producers and communities, creating rapid pathways for field trials, demonstrations, and workforce pipelines. Research is supported by competitive federal funding from NSF, USDA, DOE, and NIH. A dedicated technology transfer office manages IP, licensing, agreements, and startup formation with industry-friendly terms.